Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era

This publication has 31 references indexed in Scilit:

• Impact of Insulin-Requiring diabetes mellitus on effectiveness of reperfusion and outcome of patients undergoing primary percutaneous coronary intervention for acute myocardial infarction
  The American Journal of Cardiology, 2004
• Type 2 Diabetes and Intravenous Thrombolysis Outcome in the Setting of ST Elevation Myocardial Infarction
  Diabetes Care, 2004
• Prognostic value of admission plasma glucose and HbA_1c in acute myocardial infarction
  Diabetic Medicine, 2004
• Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction
  American Heart Journal, 2003
• Association between hyperglycemia and the no-reflow phenomenon inpatients with acute myocardial infarction
  JACC, 2003
• Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
  The Lancet, 2003
• Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy
  American Heart Journal, 2002
• Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine
  American Heart Journal, 1996
• Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus
  The American Journal of Cardiology, 1989
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985